3.5

CiteScore

2.3

Impact Factor
  • ISSN 1674-8301
  • CN 32-1810/R
Jiawei Li, Lili Feng, Yingmei Lu. Glioblastoma multiforme: Diagnosis, treatment, and invasion[J]. The Journal of Biomedical Research, 2023, 37(1): 47-58. DOI: 10.7555/JBR.36.20220156
Citation: Jiawei Li, Lili Feng, Yingmei Lu. Glioblastoma multiforme: Diagnosis, treatment, and invasion[J]. The Journal of Biomedical Research, 2023, 37(1): 47-58. DOI: 10.7555/JBR.36.20220156

Glioblastoma multiforme: Diagnosis, treatment, and invasion

  • Glioblastoma multiforme (GBM) is an essentially incurable brain tumor, which has been explored for approximately a century. Nowadays, surgical resection, chemotherapy, and radiation therapy are still the standardized therapeutic options. However, due to the intrinsic invasion and metastasis features and the resistance to chemotherapy, the survival rate of glioblastoma patients remains unsatisfactory. To improve the current situation, much more research is needed to provide comprehensive knowledge of GBM. In this review, we summarize the latest updates on GBM treatment and invasion. Firstly, we review the traditional and emerging therapies that have been used for GBM treatment. Given the limited efficiency of these therapies, we further discuss the role of invasion in GBM recurrence and progression, and present current research progress on the mode and mechanisms of GBM invasion.
  • loading

Catalog

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return